Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Editorial
Canadian Journal of Psychiatry: New Editor and New Policies
Joel Paris, MD
(PDF)

Guest Editorial
Risk Assessment in Psychiatric Practice
Kenneth Hashman, MD, FRCPC, DABPN
(PDF)

In Review
The Canadian Contribution to Violence Risk Assessment: History and Implications for Current Psychiatric Practice
Hy Bloom, LLB, MD, Christopher Webster, PhD, Stephen Hucker, MB, Karen De Freitas, MD
(PDF)

The Clinical Use of Risk Assessment
Graham D Glancy, MB, ChB, FRCPsych, FRCPC, Gary Chaimowitz, MB, ChB, FRCPC
(PDF)

The State of Contemporary Risk Assessment Research
Michael A Norko, MD, Madelon V Baranoski, PhD
(PDF)

Review Paper
Community Treatment Orders: Profile of a Canadian Experience
Ann-Marie A O’Brien, MSW, RSW, Susan J Farrell, PhD, CPsych*
(PDF)

International Dosage Differences in Fluoxetine Clinical Trials
Scott Patten, MD, Andrea Cipriani, MD, Paolo Brambilla, MD3, Michela Nosè, MD, Corrado Barbui, MD
(PDF)

Original Research
Panic-Agoraphobic Spectrum and Light Sensitivity in a General Population Sample in Italy
Letizia Bossini, MD, Mirko Martinucci, MD, Katia Paolini, MD, Paolo Castrogiovanni, MD
(PDF)

Psychotic Disorders Clinic and First-Episode Psychosis: A Program Evaluation
Suzanne Archie, MD, FRCPC, Jane Hamilton Wilson, RN, Kevin Woodward, BSc, Heather Hobbs, RN, Shelley Osborne, RN, Jean McNiven, RN
(PDF)

Screening for Mild Cognitive Impairment: Comparing the SMMSE and the ABCS
D William Molloy, MB, MRCPI, FRCPC, Timothy IM Standish, David L Lewis, PhD
(PDF)

Attention-Deficit Hyperactivity Disorder With and Without Obsessive–Compulsive Behaviours: Clinical Characteristics, Cognitive Assessment, and Risk Factors
Paul Daniel Arnold, MD, FRCPC, Abel Ickowicz, MD, FRCPC, Shirley Chen, MD, MPH, Russell Schachar, MD, FRCPC
(PDF)

Brief Communication
Validation de la version française de l’inventaire de détresse péritraumatique
Louis Jehel, MD, PhD, Alain Brunet, PhD, Sabrina Paterniti, MD, PhD, Julien D Guelfi, MD, Pr
(PDF)

Book Reviews
(PDF)

The Confinement of the Insane: International Perspectives, 1800–1965
Review by
Laurence Jerome, MD

Suicide in Children and Adolescents
Review by
Paul S Links, MD, FRCPC

Letters to the Editor
(PDF)

A Novel Form of Treatment Resistance in Anorexia Nervosa

Capgras Syndrome in the Modern Era: Self Misidentification on an ID Picture

Effectiveness of Risperidone in Delirium

Family-Oriented Rehabilitation for Unexplained Chronic Pain

Hypokalemia from Risperidone and Quetiapine Overdose

A Renewed Interest in Day Treatment

Quetiapine Therapy for Corticosteroid-Induced Mania

Editorial

Canadian Journal of Psychiatry: New Editor and New Policies

Joel Paris, MD

Dr Quentin Rae-Grant became Editor-in-Chief of The Canadian Journal of Psychiatry in 1995. He completed his term in October 2004, and I have been appointed to take his place. I would like to pay tribute to Quentin’s contributions over the last 9 years. They have notably improved standards and quality. By the end of 2005, the Journal will fall under my responsibility, but issues published over the coming year will continue to reflect Quentin’s editorial work

As the Journal focused more on research, some of its previous functions were transferred to the Bulletin. The In Review series, initiated under Quentin’s leadership, has had a particularly strong effect on the Journal’s impact. These articles, written by Canadian and international experts, regularly review areas of clinical and theoretical interest.

With the change of editorship, The Canadian Journal of Psychiatry will introduce several other changes. The Journal’s mission is to publish papers of the highest scientific quality that are relevant for the theory and practice of psychiatry. All the articles in the Journal are either empirical studies or systematic reviews. As a result, our impact factor (that is, the measure of how often articles are quoted) has steadily gone up. While Canada is small in relation to its larger neighbour country, we do not see why we cannot have an impact similar to that of journals from Britain and Scandinavia.

Our plans for the future are to continue on the same path. The Editorial Board has been expanded to ensure that we have enough committed reviewers to process submissions more rapidly. We are grateful to all our reviewers, whether Board members or not, for providing, without any compensation, expert peer commentary that maintains the quality of the articles we publish.

The most important change is that the Editorial Board has decided to raise the bar for publication. In the future, we will not accept articles unless they receive strong recommendations from the peer review process. Also, I will not send out articles for review unless they correspond to our mandate. As a result, fewer submitted articles will be accepted. This new policy has several advantages. As our impact factor continues to go up, we can attract more high-quality submissions. At the same time, a higher bar allows us to institute a rapid-publication policy that will attract many authors. Submission to the Journal will now be electronic, as has become standard for most psychiatric journals. This change will also allow us to process manuscripts more rapidly. In accordance with recent developments elsewhere, we will also ask that all articles be accompanied by a disclosure statement indicating whether the authors have any competing interests.

The Journal will be experimenting, publishing 14 issues in 2005. Even so, we have limited space at our disposal. Thus we must make other changes to better use that space. One is that letters to the editor will only be printed if they comment on a published article. Consequently, we will no longer accept case reports as letters.

The Canadian Journal of Psychiatry is 50 years old this year, and we will publish a special section to mark our anniversary. Over the last half-century, we have provided articles of real interest to practising psychiatrists and researchers. Our trajectory for the future will be to increase scientific quality while remaining relevant to clinical practice.